COMPANY PROFILE · UPDATED 18 NOV 2025

Deepcell

Deepcell uses AI to isolate and capture cells based on morphological features for multiple research and translational applications.

deepcellbio.com ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2017
Headcount: 77
Open roles: 2
Last raised: Series B · Sign in to view

TECH STACK

How Deepcell builds

LEADERSHIP

Founders & key people

Mahyar Salek

CTO at Deepcell

DeepcellGOOGLEEmotifulMicrosoft CorporationCUTEC - Cambridge University Technology andCentrum Wiskunde & InformaticaUniversity of CambridgeUniversity of Southern CaliforniaSharif University of Technology

Euan Ashley

Professor of Medicine and Genetics at Stanford University

SVEXAStanford UniversityStanford Health CareDeepcellPERSONALISASTRAZENECAUniversity of OxfordUniversity of GlasgowChrist Church Oxford

Maddison Masaeli

CEO at Deepcell

DeepcellStanford University School of MedicineStanford UniversityGenapsysUniversity of California Los AngelesHarvard-MIT HSTUniversity of California Los AngelesSharif University of TechnologyNortheastern University

OPEN ROLES

Hiring at Deepcell

FUNDING

Capital raised

Total raised

$98,000,000

Investors

Andreessen HorowitzBow CapitalBridger HealthcareCasdin CapitalDCVCFifty YearsHorizons VenturesJeff DeanKoch Disruptive TechnologiesMatt McIlwainStanford University

Funding rounds

Series B
Koch Disruptive Technologies, Andreessen Horowitz, Bridger Healthcare, Horizons Ventures, Casdin Capital, Bow Capital, Jeff Dean, Matt McIlwain
$73MMar 16, 2022
Series A
Bow Capital, Andreessen Horowitz, Jeff Dean, Fifty Years, Stanford University, DCVC
$20MDec 6, 2020
Seed
Andreessen Horowitz, Stanford University, DCVC, Fifty Years
$5MDec 26, 2017

Funding data via Diffbot